Cancer drugs fund 'to be extended'

Written By Unknown on Sabtu, 28 September 2013 | 15.36

28 September 2013 Last updated at 04:06 ET
Jeremy Hunt

Please turn on JavaScript. Media requires JavaScript to play.

Health Secretary Jeremy Hunt said cancer sufferers in Wales were renting homes in England to access drugs

A £200m-a-year fund for life-enhancing cancer drugs is to continue until 2016, the prime minister has announced.

The Cancer Drugs Fund (CDF) was set up in 2011 to help patients in England access certain drugs before they get approval for widespread NHS use.

The scheme was due to end next year, but David Cameron has pledged £400m to keep it running.

Cancer charities have welcomed the move, but Labour accused the prime minister of "letting down" patients.

Head of policy at Cancer Research, Sara Osborne, praised the valuable role the fund would play in battling the disease and highlighted the tens of thousands of people who received treatment because of it.

She said: "There's about 30 drugs that are available on the Cancer Drugs Fund, and over the last three years about 34,000 patients have had treatment that they would not have otherwise had, had the fund not existed."

'Special case'

The aim of the CDF was to make it easier for medics to prescribe treatments even if they have not yet been approved by the National Institute for Health and Care Excellence (Nice).

Continue reading the main story

It has also addressed some of the historic inequities that have existed for people with rarer cancers."

End Quote Andrew Wilson Chief executive of the Rarer Cancers Foundation

The scheme was set to run until 2014 and campaigners raised concerns about where patients would turn for help when the funding ceased.

Health Secretary Jeremy Hunt said cancer was a special case.

He said: "We particularly make exceptions for rarer diseases which only affect small numbers of people, and the other area we make that exception for are these cancer drugs because we think it is the number one killer, and we do think that we had a particular problem with a lack of access to these drugs."

Andrew Wilson, chief executive of the Rarer Cancers Foundation, said: "The Cancer Drugs Fund has made a huge difference to cancer patients in England, significantly improving the quality of treatment available to people with advanced forms of cancer.

"It has also addressed some of the historic inequities that have existed for people with rarer cancers, ensuring that access to treatment is not denied simply because you are unlucky enough to have a rare form of cancer.

"This is a compassionate, common sense announcement which will be warmly welcomed by many thousands of cancer patients."

Continue reading the main story

An extension of the Cancer Drugs Fund in England means a radical overhaul in the NHS drugs pricing system is now unlikely.

Next year was meant to mark the start of value-based pricing, a system proposed by former Health Secretary Andrew Lansley to promote a closer link between the price the NHS pays and the value a medicine offers.

It could have led to higher price thresholds for medicines for diseases with a greater burden of illness or in areas where there is un-met need, or if it could be demonstrated that there would be wider benefits, such as getting people back to work.

Some of these elements are to be incorporated into the work of the drugs advisory body the National Institute of Health and Care Excellence from January.

But this announcement effectively signals a light-touch version of what was first envisaged.

So far more than 34,000 patients have benefited from the fund and the charity estimates that 16,500 extra patients will benefit each year as a result of the extension.

Mr Cameron said: "When I became prime minister three years ago many patients with rare cancers were being denied life-saving treatments.

"That is why we created the Cancer Drugs Fund, it is why we are extending it, and it is why we are partnering with Cancer Research UK to conduct new research into the effectiveness of cancer drugs.

"It is only because we have protected health spending that we can afford these life saving treatments."

Dr Andrew Protheroe, consultant in medical oncology at The Churchill Hospital in Oxford, also backed the extension of the scheme.

He said: "The more treatment options that are available to me, the better job I feel I can do for my patients.

"There is nothing more frustrating than knowing there is an effective, licensed, evidence-based treatment available which I am not allowed to use.

"It is like trying to do your job with one hand tied behind your back.

"Before the Cancer Drugs Fund, doctors were not able to use a whole range of drugs which were part of standard practice in other countries.

"This fantastic announcement means we won't have to go back to those days."

Networks scrapped

However, BBC health correspondent Nick Triggle said the move does raise questions about the introduction of a new way of assessing drugs that had been expected to start next year.

Next year was meant to mark the start of value-based pricing, a system proposed by previous health secretary Andrew Lansley to ensure there is a closer link between the price the NHS pays and the value that a medicine offers.

There will now be no full blown overhaul although drug advisory body NICE will be looking to make some changes to improve the assessment process from January.

Shadow health minister Liz Kendall said the government was "letting down cancer patients".

She highlighted the fact that expert cancer networks - set up to improve access to high quality services - were scrapped during the reorganisation of the NHS earlier this year.

She added: "David Cameron should also stand up to the tobacco lobby rather than caving in to them over standardised cigarette packaging, which experts say would be a powerful weapon in the long-term fight against cancer."

Alongside plans to extend the fund, Mr Cameron also announced that Genomics England - a government-owned organisation tasked with mapping the DNA of 100,000 patients with cancer and rare diseases - will begin a partnership with Cancer Research UK.


Anda sedang membaca artikel tentang

Cancer drugs fund 'to be extended'

Dengan url

http://sarapanoatmeal.blogspot.com/2013/09/cancer-drugs-fund-to-be-extended.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Cancer drugs fund 'to be extended'

namun jangan lupa untuk meletakkan link

Cancer drugs fund 'to be extended'

sebagai sumbernya

0 komentar:

Posting Komentar

techieblogger.com Techie Blogger Techie Blogger